EULAR 2022: Video met Prof. dr. Willem Lems, Amsterdam UMC

Sessie: RA treatment: modern strategies and new molecules OP0266 Treatment discontinuation due to adverse events as an overall measure of tolerance and safety of JAK-inhibitors: An international collaboration of registries of rheumatoid arthritis patients (the “JAK-pot” study).